中华骨科杂志
中華骨科雜誌
중화골과잡지
CHINESE JOURNAL OF ORTHOPAEDICS
2014年
6期
599-604
,共6页
胡旭栋%周宗科%裴福兴%马俊%沈彬%杨静%康鹏德
鬍旭棟%週宗科%裴福興%馬俊%瀋彬%楊靜%康鵬德
호욱동%주종과%배복흥%마준%침빈%양정%강붕덕
关节成形术,置换,膝%氨甲环酸%失血,手术%有效性研究
關節成形術,置換,膝%氨甲環痠%失血,手術%有效性研究
관절성형술,치환,슬%안갑배산%실혈,수술%유효성연구
Arthroplasty,replacement,knee%Tranexamic acid%Blood loss,surgical%Validation studies
目的 探讨在全膝关节置换围手术期氨甲环酸不同使用方法的有效性和安全性.方法 2013年2至5月150例行初次单侧全膝关节置换的女性骨关节炎患者随机分为三组,每组50例.分别在关闭切口前静脉滴注氨甲环酸10 mg/kg(单次使用组);关闭切口前静脉滴注氨甲环酸10 mg/kg、术后3h再次按该剂量重复使用(重复使用组);不使用氨甲环酸(对照组).比较三组引流量、总失血量、隐性失血量、术后不同时间血红蛋白、输血患者比例、深静脉血栓和肺栓塞发生率.结果 对照组引流量(447.2±101.9) ml,大于单次使用组(273.6±99.6) ml和重复使用组(168.5±80.8) ml,差异有统计学意义.对照组总失血量(1 100.8±288.3) ml,大于单次使用组(959.1±291.7) ml和重复使用组(818.7±206.9) ml,差异有统计学意义.三组隐性失血量的差异无统计学意义.对照组术后第1、3、5天的血红蛋白均低于单次使用组和重复使用组,重复使用组均高于单次使用组,差异有统计学意义.三组输血患者比例分别为8.0%(4/50)、6.0%(3/50)和22.0%(11/50),对照组高于单次使用组和重复使用组,差异有统计学意义.术后90 d内均未出现症状性深静脉血栓和肺栓塞.结论 全膝关节置换术中关闭切口前静脉滴注氨甲环酸10 mg/kg能有效减少围手术期失血量和降低输血患者比例,术后3h重复使用能进一步减少失血量,但不能进一步降低输血患者比例.使用氨甲环酸不增加深静脉血栓和肺栓塞发生的风险.
目的 探討在全膝關節置換圍手術期氨甲環痠不同使用方法的有效性和安全性.方法 2013年2至5月150例行初次單側全膝關節置換的女性骨關節炎患者隨機分為三組,每組50例.分彆在關閉切口前靜脈滴註氨甲環痠10 mg/kg(單次使用組);關閉切口前靜脈滴註氨甲環痠10 mg/kg、術後3h再次按該劑量重複使用(重複使用組);不使用氨甲環痠(對照組).比較三組引流量、總失血量、隱性失血量、術後不同時間血紅蛋白、輸血患者比例、深靜脈血栓和肺栓塞髮生率.結果 對照組引流量(447.2±101.9) ml,大于單次使用組(273.6±99.6) ml和重複使用組(168.5±80.8) ml,差異有統計學意義.對照組總失血量(1 100.8±288.3) ml,大于單次使用組(959.1±291.7) ml和重複使用組(818.7±206.9) ml,差異有統計學意義.三組隱性失血量的差異無統計學意義.對照組術後第1、3、5天的血紅蛋白均低于單次使用組和重複使用組,重複使用組均高于單次使用組,差異有統計學意義.三組輸血患者比例分彆為8.0%(4/50)、6.0%(3/50)和22.0%(11/50),對照組高于單次使用組和重複使用組,差異有統計學意義.術後90 d內均未齣現癥狀性深靜脈血栓和肺栓塞.結論 全膝關節置換術中關閉切口前靜脈滴註氨甲環痠10 mg/kg能有效減少圍手術期失血量和降低輸血患者比例,術後3h重複使用能進一步減少失血量,但不能進一步降低輸血患者比例.使用氨甲環痠不增加深靜脈血栓和肺栓塞髮生的風險.
목적 탐토재전슬관절치환위수술기안갑배산불동사용방법적유효성화안전성.방법 2013년2지5월150례행초차단측전슬관절치환적녀성골관절염환자수궤분위삼조,매조50례.분별재관폐절구전정맥적주안갑배산10 mg/kg(단차사용조);관폐절구전정맥적주안갑배산10 mg/kg、술후3h재차안해제량중복사용(중복사용조);불사용안갑배산(대조조).비교삼조인류량、총실혈량、은성실혈량、술후불동시간혈홍단백、수혈환자비례、심정맥혈전화폐전새발생솔.결과 대조조인류량(447.2±101.9) ml,대우단차사용조(273.6±99.6) ml화중복사용조(168.5±80.8) ml,차이유통계학의의.대조조총실혈량(1 100.8±288.3) ml,대우단차사용조(959.1±291.7) ml화중복사용조(818.7±206.9) ml,차이유통계학의의.삼조은성실혈량적차이무통계학의의.대조조술후제1、3、5천적혈홍단백균저우단차사용조화중복사용조,중복사용조균고우단차사용조,차이유통계학의의.삼조수혈환자비례분별위8.0%(4/50)、6.0%(3/50)화22.0%(11/50),대조조고우단차사용조화중복사용조,차이유통계학의의.술후90 d내균미출현증상성심정맥혈전화폐전새.결론 전슬관절치환술중관폐절구전정맥적주안갑배산10 mg/kg능유효감소위수술기실혈량화강저수혈환자비례,술후3h중복사용능진일보감소실혈량,단불능진일보강저수혈환자비례.사용안갑배산불증가심정맥혈전화폐전새발생적풍험.
Objective To explore the perioperative efficiency and safety of different regimen of tranexamic acid (TXA) in total knee arthroplasty (TKA).Methods From February 2013 to May 2013,150 female patients with knee osteoarthritis underwent unilateral TKA were randomly divided into three groups,50 cases in each group.Patients received 10 mg/kg TXA by fast intravenous infusion before closing the wound in first group (single dose group),patients in second group received two doses of 10 mg/kg TXA before closing the wound and 3 hours postoperation (repeated dose group),patients in the third group didn't receive TXA (control group).The postoperative blood loss via drainage,the total blood loss,the hidden blood loss,the postoperative hemoglobin concentration at different times and the numher of patients need blood transfusion were recorded.All patients were observed for detecting deep vein thrombosis (DVT) by the color doppler ultrasonography within 5 days postoperation,and the symptomatic DVT and pulmonary embolism (PE) were observed within 90 days postoperation.Results The blood loss via drainage was significantly less in the single dose group (273.6±99.6 ml) and repeated dose group (168.5±80.8 ml) compared with the control group (447.2±101.9 ml),and it was significantly less in the repeated dose group than the single dose group; the total blood loss was significantly less in the single dose group (959.1±291.7 ml) and repeated dose group (818.7±206.9 ml) compared with the control group (1 100.8±288.3 ml),and it was significantly less in the repeated dose group than in the single dose group; there was no differ ences about the hidden blood loss among the three groups.The hemoglobin concentration was significantly higher in the single dose group and repeated dose group than in the control group in day 1,3 and 5 postoperation; and it was significantly higher in the repeated dose group compared with the single dose group.The ratio of transfusion was significantly less in the single and repeated dose groups than in the control group,but no differences exists between the single dose group and repeated dose group.There was no DVT in all of the three groups within 5 days postoperation,and there was no symptomatic DVT and PE in all of the three groups within 90 days.Conclusion 10 mg/kg of TXA infused intravenous before closing the wound is effective and safe in TKA,another dose 3 hours postoperation is much more effective and will not increase the danger of DVT and PE.